Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R. Kalra, Claes Christian Strom, Philip A. Kalra et al.|The Lancet|2022Cited by 367
Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trialPhilip M. Bath, Nadia Frowd, Polly Scutt et al.|The Lancet|2019Cited by 196